173 related articles for article (PubMed ID: 16227743)
1. [Clinical study of porous gelatin sphere (YM 670) in transcatheter arterial embolization].
Yamada R; Sawada S; Uchida H; Kumazaki T; Hiramatsu K; Ishii H; Nakao N; Nakamura H; Taguchi T
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1431-6. PubMed ID: 16227743
[TBL] [Abstract][Full Text] [Related]
2. [The movement of antineoplastic solutions in transcatheter hepatic arterial embolization].
Tsuda M; Yamada R; Sato M; Tanaka K; Nomura S; Tsuzi T; Terada M; Shioyama Y; Maeda M; Kishi K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 May; 50(5):504-11. PubMed ID: 2167464
[TBL] [Abstract][Full Text] [Related]
3. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
Maluccio MA; Covey AM; Porat LB; Schubert J; Brody LA; Sofocleous CT; Getrajdman GI; Jarnagin W; Dematteo R; Blumgart LH; Fong Y; Brown KT
J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
[TBL] [Abstract][Full Text] [Related]
6. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
[TBL] [Abstract][Full Text] [Related]
7. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
Lin WY; Wang SJ; Yeh SH
Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
[TBL] [Abstract][Full Text] [Related]
8. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS].
Taniguchi K; Kaminaga T; Sakon M; Umeshita K; Yamada T; Takeda Y; Higaki N; Aoki T; Ohzato H; Hasuike Y; Gotoh M; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494
[TBL] [Abstract][Full Text] [Related]
9. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
Sakon M; Kambayashi J; Taniguchi K; Yoshida T; Shiba E; Kawasaki T; Tsuji Y; Yukawa M; Murata K; Gotoh M
Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
Yamazaki H; Nishimoto N; Oi H; Matsushita M; Ogata A; Shima Y; Inoue T; Tang JT; Yoshizaki K; Kishimoto T
Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic artery embolization for primary hepatic carcinoma].
Ye WJ
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):151-3. PubMed ID: 2553366
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial embolization for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complicating hepatocellular carcinoma.
Izaki K; Sugimoto K; Sugimura K; Hirota S
Radiat Med; 2004; 22(3):155-62. PubMed ID: 15287530
[TBL] [Abstract][Full Text] [Related]
13. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J
Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
[TBL] [Abstract][Full Text] [Related]
14. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
Kishimoto W; Nakao A; Takagi H; Hayakawa T
Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
[TBL] [Abstract][Full Text] [Related]
15. [Our initial experience with SMANCS in TAE for liver cancer].
Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of caerulein in suppressing post-TAE complications of the gallbladder].
Akamatsu K; Miyauchi S; Yasuhara Y; Mogami H; Nishimura N; Ohshima K; Ohta Y
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1094-9. PubMed ID: 3032112
[TBL] [Abstract][Full Text] [Related]
17. Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization.
Nitta N; Ohta S; Tanaka T; Takazakura R; Nagatani Y; Kono N; Sonoda A; Seko A; Furukawa A; Takahashi M; Murata K; Tabata Y
Eur J Radiol; 2008 Sep; 67(3):536-40. PubMed ID: 17826023
[TBL] [Abstract][Full Text] [Related]
18. Emergency transcatheter embolization of ruptured hepatocellular carcinomas with tortuous conventional or aberrant hepatic vascular anatomy, or parasitic supply.
Lau K; Wong WW; Chan JK; Kan WK; Leung JL; Lee AS; Lee LT; Lee GY
Australas Radiol; 2007 Apr; 51(2):190-5. PubMed ID: 17419870
[TBL] [Abstract][Full Text] [Related]
19. [Optimal size of embolic material in transcatheter arterial embolization of the liver].
Sonomura T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 May; 54(6):489-99. PubMed ID: 8028956
[TBL] [Abstract][Full Text] [Related]
20. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
